Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000002

Chief Commercial Officer sold 2,902 shares at $22.32 ($64,773)

  • Chief Commercial Officer acquired 8,475 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Milanova Tsveta Chief Commercial Officer 2024-01-03 Option exercise 10b5-1 +8,475 12,306 D
Milanova Tsveta Chief Commercial Officer 2024-01-05 Sale 10b5-1 −2,902 $22.32 $64,773 9,404 D
Derivatives
Milanova Tsveta Chief Commercial Officer 2024-01-03 Option exercise · Restricted stock units 10b5-1 −8,475 16,951 D
Open-market sales · 2,902 sh · avg $22.32 · $64,773
Loading xslF345X05/wk-form4_1704489026.xml…